INTRODUCTION
The estrogen receptor (ER) is a member of a superfamily of transcription factors and is activated by binding the endogenous hormone 17β-estradiol (E2) or other ER agonists (1) (2) (3) (4) (5) . The bound receptor forms a nuclear homodimer which interacts with cis-genomic estrogen responsive elements (EREs) in target genes, resulting in transactivation. The ER and other members of the superfamily contain two distinct activation functions (AFs) which are located within the N-terminal (AF-1) and C-terminal (AF-2) domains of the ER (6) (7) (8) (9) (10) (11) (12) . The roles of AF-1 and AF-2 are dependent on the cellular and promoter context and ligand, however, in some E2-responsive tissues, both AF-1 and AF-2 synergistically contribute to E2-induced gene expression (6) .
ER-mediated transactivation is now recognized as a more complex process regulated by interactions with co-activator and/or co-repressor proteins and other transcription factors, by binding directly to diverse DNA elements or by indirectly enhancing DNA binding via protein-protein interactions (13) . These factors, coupled with identification of a second form of the ER (ER β ) (14, 15) and expression of multiple variant forms of ER α (16, 17) , illustrate the multiple variables which modulate E2-induced responses, and this diversity undoubtedly plays an important role in tissue-specific gene expression. Studies in this laboratory have utilized the cathepsin D gene as a model for understanding mechanisms of ER-mediated induction and cross-talk between the ER and aryl hydrocarbon receptor (AhR) signaling pathways (18) (19) (20) . In the MCF-7 human breast cancer cell line two functional E2-responsive enhancer elements have been identified, namely an Sp1(N) 23 ERE half-site (-199 to -165), which binds an ER/Sp1 protein complex, and an imperfect palindromic ERE (-119 to -107), which binds the ER homodimer. This represents a novel gene promoter containing at least two different enhancer sequences in the 5′-proximal region.
Ligands such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which bind the AhR, exhibit a broad spectrum of anti-estrogenic activities, including inhibition of mammary tumor growth in rodent models (21) (22) (23) and E2-induced gene expression in breast cancer cell lines (reviewed in 24) . Cathepsin D has been used in this laboratory as a model to investigate the mechanism of AhR-mediated anti-estrogenicity (18, 19, 25) . It was reported that interaction of the liganded nuclear AhR complex with a dioxin-responsive element (DRE) core binding sequence (-CACGC-) located within the Sp1(N) 23 ERE half-site resulted in inhibition of ER/Sp1 complex formation and loss of E2 inducibility of a plasmid containing this motif (19) . The role of inhibitory DRE (iDRE) sequences has also been confirmed for AhR-mediated inhibition of E2-induced heat shock protein (Hsp) 27 and pS2 gene expression (26, 27) .
In vivo exonuclease III footprinting showed that E2 induced a footprint at an upstream GC-rich site (-145 to -135) in the cathepsin D gene promoter (20) and this site confers E2 responsiveness on promoter-reporter constructs containing a -145 to -119 oligonucleotide insert. Surprisingly, an adjacent core pentanucleotide DRE sequence also played a role in E2-induced transactivation in the absence of exogenous AhR ligand. The results suggest that the unbound nuclear AhR complex, through interaction with an adjacent core DRE sequence, enhances ER/Sp1-mediated induction of gene expression and this represents an example of an endogenous role for the nuclear AhR complex.
MATERIALS AND METHODS

Chemicals, cells, antibodies and oligonucleotides
MCF-7 and MDA-MB-231 cells were obtained from the American Type Culture Collection (ATCC, Rockville, MD). Cells were maintained in minimum essential medium (MEM) with phenol red and supplemented with 10% fetal calf serum (FCS) as previously described (18) (19) (20) . Cells were grown in Dulbecco's modified Eagle's medium nutrient mixture/F-12 Ham medium (DME F-12) without phenol red and 2.5% stripped FCS for 2 days before dosing. DME F-12 without phenol red, phosphate-buffered saline (PBS), acetyl CoA, 17β-estradiol (E2) and 100× antibiotic/antimycotic solution were purchased from Sigma Chemical Company (St Louis, MO (Grand Island, NY). Human ER monoclonal antibody H222 was purchased from Abbott Laboratories (Abbott Park, IL). Sp1 monoclonal antibody (Sp1 Ab) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The human estrogen receptor (hER) and variant 11C-ER expression plasmids were provided by Dr Ming-jer Tsai (Baylor College of Medicine, Houston, TX) and Dr Pierre Chambon (France) respectively. AhR and AhR nuclear translocator (Arnt) expression plasmids were kindly provided by Dr Bradfield (Northwestern University, Chicago, IL) and Dr Hankinson (UCLA, Los Angeles, CA) respectively and the antisense Arnt expression plasmid was derived from this construct as described (18) . The TNT T7/SP6 coupled reticulocyte lysate system and Sp1 protein were purchased from Promega (Madison, WI). The plasmid preparation kit was purchased from Qiagen (Santa Clarita, CA). Polyacrylamide (40%) was obtained from National Diagnostics (Atlanta, GA). All other chemicals and biochemicals were the highest quality available from commercial sources.
The oligonucleotide structures and their descriptors are given below and are used throughout the manuscript. The Sp1 and core DRE sites are underlined, the mutated bases are indicated with an asterisk and the HindIII and BamHI linker sequences are italicized. The numbers in parentheses indicate the positions within the 5′-promoter region of the cathepsin D gene. The numbering is based on +1 as the first nucleotide of the translation initiation codon as described (29) . Consensus Sp1 oligo (sense strand), 5′-AGCTTATTCGATCGGGGCGGGGCGAGCG-3′; consensus mutant Sp1 m oligo (sense strand), 5′-AGCTTATTC-GATCGA*A*GCGGGGCGAGCG-3′; CD/L (-119 to -145) oligo (antisense strand), 5′-GATCCGCGGCCGGCGTGCGC-GGGGCGGGGCGGA-3′; CD/L M1 (-119 to -140) oligo (antisense strand), 5′-GATCCGCGGCCGGT*T*TT*CGCGGGGCG-GGGCGGA-3′; CD/L M2 (-119 to -145) oligo (antisense strand), 5′-GATCCGCGGCCGGCGTGCGCT*T*GT*A*T*GA*A*A *T*GA-3′; CD/L M3 (-119 to -145) oligo (antisense strand), 5′-GATCCGCGGCCGGT*T*TT*CGCT*T*GT*A*T*GA* A*A*T*GA-3′; DRE 3 
Cloning
The pBLTATA-CAT plasmid was made by digesting the pBLCAT2 vector with BamHI and XhoI to remove the thymidine kinase promoter. The double-stranded E1B-TATA oligonucleotide containing complementary 5′-overhangs was then inserted into the corresponding sites (31) . Wild-type CD/L and its mutants CD/L M1 , CD/L M2 and CD/L M3 were cloned into pBLTATA-CAT at the HindIII and BamHI sites to give plasmids pCD/L, pCD/L M1 , pCD/L M2 and pCD/L M3 respectively. pSp1 contained the consensus Sp1 oligonucleotide insert. The wild-type DRE 3 and its mutant DRE M3 were also ligated into pBLTATA-CAT using HindIII and BamHI sites to give plasmids pDRE 3 and pDRE 3M respectively. All the ligation products were transformed into DH5α competent Escherichia coli cells, plasmids were isolated and correct clonings were confirmed by restriction enzyme mapping and DNA sequencing using a Sequitherm cycle sequencing kit from Epicentre Technologies (Madison, WI). Plasmid preparations for transfections were carried out by alkaline lysis followed by cesium chloride gradient centrifugations (twice) or with a Qiagen Plasmid Mega Kit (Santa Clarita, CA).
Transient transfection and CAT assays
Cultured MCF-7 and MDA-MB-231 cells were transiently transfected by the calcium phosphate method with 10 µg reporter plasmids and 5 µg either plasmid hER or empty construct (pcDNA3.1; Invitrogen Inc., Carlsbad, CA) as a control as previously described (20, 25, 31) . Experiments with antisense Arnt expression utilized 5 µg pCD/L, 2.5 µg ER expression plasmid and 10 or 30 µg Arnt antisense plasmid; pcDNA3 plasmid was also added so that the amount of plasmid/plate was constant (37.5 µg). The percent conversion into acetylated chloramphenicol was quantitated using the counts/min obtained from a Betagen Betascope 603 blot analyzer. CAT activity was calculated as the percentage of that observed in cells treated with DMSO (arbitrarily set at 100%) and values are expressed as means ± SE for at least three separate experiments.
Electrophoretic mobility shift assays
Plasmids containing the full-length hER, AhR and Arnt cDNAs were used to in vitro transcribe and translate the corresponding proteins in a rabbit reticulocyte lysate kit (TNT coupled reticulocyte lysate system; Promega, Madison, WI). Parallel reactions with [ 35 S]methionine were also performed to monitor translational efficiency. Equal amounts of expressed AhR and ARNT were mixed and incubated on ice for 3 h in the absence of any exogenous ligand prior to electrophoretic mobility shift assays. In vitro transcribed and translated proteins were aliquoted and stored at -80_C. Gel electrophoretic mobility shift assays utilizing different amounts of various proteins were carried out as previously described (20, 29, 31) . Protein-DNA binding was visualized by autoradiography and quantitated using the Betagen Betascope 605 blot analyzer and subjected to autoradiography using Kodak X-Omat film for at least 2 h at -80_C.
Co-immunoprecipitation
35 S-Labeled ER was synthesized and incubated with AhR/ARNT in the presence or absence of 10 ng Sp1 protein in binding buffer [12 mM HEPES-NaOH, pH 7.9, 12% (w/v) glycerol, 30 mM KCl, 0.12 mM EDTA, 0.3 mM dithiothreitol, 0.1 mg/ml phenylmethylsulfonyl fluoride (PMSF), 57 µg/ml aprotinin and 1 mM sodium orthovanadate]. After incubation for 1 h at 0_C, 1 µg anti-ER, anti-Sp1, anti-AhR or anti-ARNT antibodies were added. After further incubation at 4_C for 1 h, 20 µl Agarose A/G PLUS (Santa Cruz Biotechnology, Santa Cruz, CA) was added and incubated (gently rocking) for 3 h at 4_C. The bound complex was then washed four times with RIPA buffer (PBS plus 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 0.1 mg/ml PMSF, 57 µg/ml aprotinin and 1 mM sodium orthovanadate). The proteins were resolved on 8.5% SDS-polyacrylamide gels, dried and visualized by autoradiography. 14 C-Labeled protein molecular weight standards (Amersham Corp., Arlington, IL) were used to determine the molecular weight of precipitated 35 S-labeled ER.
Immunofluorescence microscopy for localization of AhR and ARNT in MCF-7 cells
The specific antibodies against mouse AhR (A-1) and mouse ARNT (R-1) and the immunofluorescence microscopy assay have been previously described (32) (33) (34) . On average, 15-20 fields (5-20 cells each) were evaluated on each slip and three were photographed to generate the raw data. The concentrations of antibodies used are detailed in the text.
UV DNA cross-linking
For cross-linking studies, 10 pmol synthetic oligonucleotide (CD/L) were annealed to 10 pmol cross-linked primer sequence. The annealed template was end-filled with the Klenow fragment of DNA polymerase in the presence of 0.1 µM dGTP, dATP and bromodeoxyuridine (BrdU) and 1 µM [ 32 P]dCTP and was designated the BrdU-substituted DRE oligonucleotide. Nuclear extracts (10 µg) from untreated MCF-7 cells were incubated with the BrdU-substituted DNA for 15 min at 20_C following a 15 min incubation at 20_C with 400 ng poly(dI·dC) in HEGD buffer for 10 min, followed by a 5 min incubation at 20_C with unlabeled excess competitor. Incubation mixtures were irradiated using a Fotodyne UV transilluminator at >205 nm for 30 min at 20_C. Samples were then mixed with 20 µl SDS loading buffer, heated to 95_C for 5 min and subjected to electrophoresis on 8.5% SDS-polyacrylamide gels. 
Statistical analysis
Statistical significance was determined by ANOVA and Scheffe's test and the levels of probability are noted. Results are expressed as means ± SE of at least three replicate experiments.
RESULTS
E2 responsiveness of pCD/L and constructs containing mutations in the CD/L insert
E2 responsiveness of pCD (-145 to -101) was due, in part, to an imperfect palindromic ERE (-119 to -107) identified within the 3′-region of this sequence (20) . pCD/L contains the more 5′-upstream (-119 to -145) sequence that has two overlapping Sp1 binding sites (-145 to -140 and -140 to -135) and previous studies in this laboratory have demonstrated that E2 responsiveness can be observed via ER/Sp1 interactions with GC-rich Sp1 binding sites (35) . In MCF-7 cells treated with E2 and transiently transfected with pCD/L there was a 6.8-fold increase in CAT activity, whereas pCD/L M2 , which contains a mutation in the Sp1 site (-145 to -135) was not E2 responsive (Fig. 1) . The requirement for hER co-transfection in ER-positive breast cancer cells has previously been reported for other constructs containing E2-responsive promoter inserts derived from the cathepsin D (18) (19) (20) 29) , pS2 (36), progesterone receptor (37), c-myc (38) and Hsp27 (31, 35) genes. E2 also induced CAT activity in ER-negative MDA-MB-231 cells transiently transfected with pCD/L plus hER or 11C-ER (Fig.  1B) and inducibility was not observed in MDA-MB-231 cells transiently transfected with pCD/L alone or pBL/TATA (no CD gene promoter insert) plus hER (data not shown). These results are consistent with formation of a transcriptionally active ER/Sp1 complex, as previously reported using a pSp1 plasmid containing a consensus Sp1 oligonucleotide insert (35) .
Binding of CD/L and Sp1 protein was determined in gel mobility shift assays with Sp1 protein and [ 32 P]CD/L. The results illustrated in Figure 2 show that Sp1 protein bound to wild-type dose-dependent increase in formation of an Sp1-[ 32 P]CD/L retarded band (Fig. 3, lanes 2-5) . In the presence of 1 µl in vitro translated ER (in a total reaction volume of 10 µl), the dose-dependent increase in retarded band formation by the same concentration gradient of Sp1 protein was increased 1.8-to 2.7-fold (lanes 6-9). The intensity of the retarded band was significantly decreased by competition with 100-fold excess of unlabeled Sp1 oligonucleotide (lane 10) but not by a 100-fold excess of mutant Sp1 (lane 11). Thus, ER enhanced Sp1-CD/L retarded band formation but did not form a supershifted complex which could be detected by a gel mobility shift assay.
A core DRE motif (-130 to -126) adjacent to GC-rich sites (-145 to -135) within CD/L is required for E2 responsiveness E2 did not induce CAT activity in cells transfected with pCD/L M1 or pCD/L M3 , which contain mutations in the core DRE site or both the DRE and GC-rich sites (Fig. 1) , and E2 does not modulate Ah responsiveness in MCF-7 cells (39) . AhR/ARNT does not bind the core DRE (GCGTG) sequence or [ 32 P]CD/L in gel mobility shift assays (data not shown). However, in competitive binding studies using the consensus [ 32 P]DRE (Fig. 4A) , AhR/ARNT formed a retarded band (lane 3) which was competitively decreased by co-incubation with an excess of unlabeled DRE and CD/L but not by CD/L M1 (containing a core DRE mutation) (lanes 4-6 respectively). Nuclear extracts from untreated MCF-7 cells also bound the consensus [ 32 P]DRE to give a retarded band (data not shown). In addition, nuclear extracts from MCF-7 cells cross-link with BrdU-substituted [ 32 MCF-7 cells were grown on glass coverslips in the presence of charcoal-extracted fetal bovine serum, fixed and stained with antibodies against the AhR as described (32,34; Fig. 5i ). The pattern of AhR staining was predominantly nuclear in the absence of any exogenously added AhR ligand, with minimal reactivity within the cytoplasm (Fig. 5A-C) . When MCF-7 cells were treated with 1 nM TCDD for 1 h and then fixed and stained, the staining remained predominately nuclear, although the intensity of the signal appeared to be slightly increased when compared with untreated cells (Fig. 5D) . Importantly, MCF-7 cells stained with an identical concentration of pre-immune IgG did not exhibit significant staining within the nucleus, but showed a low level of staining in the perinuclear and cytoplasmic regions (Fig. 5E ). This strongly suggests that the nuclear staining observed in MCF-7 cells is the result of AhR protein within the nucleus and not non-specific reactivity of the antibody. These results are consistent with nuclear localization of the AhR in HeLa cells (40) , NIH 3T3 fibroblasts and A7 smooth muscle cells (R.Pollenz, unpublished results), but are in contrast to the predominantly cytoplasmic location of AhR in unstimulated Hepa-1c1c7 cells ( Fig. 5G; 32,34 ). ARNT protein showed intense nuclear staining, consistent with previous reports (Fig. 5F) (33) .
α-Naphthoflavone (α-NF) is an AhR antagonist that preferentially forms a cytosolic AhR complex (41) and, in MCF-7 cells treated with E2 and transiently co-transfected with pCD/L and hER, co-treatment with 0.5 or 2.0 µM αNF decreased E2-induced activity by >40% (Fig. 5ii) . E2-induced transactivation was also significantly decreased after co-transfection with antisense Arnt expression plasmid (Fig. 5iii) , suggesting that hormoneresponsiveness of CD/L is dependent on nuclear AhR.
The role of the DRE sequence and AhR complex in formation of the ER/Sp1-CD/L complex was further investigated by gel mobility shift assays (Fig. 6A) (Fig. 6B, lane 2) and co-incubation with ER increased the intensity of this band (lane 3). However, co-incubation with the AhR/ARNT proteins did not further enhance the retarded (ii) Effects of α-naphthoflavone and (iii) antisense Arnt expression on induction of CAT activity by E2 in MCF-7 cells co-transfected with pCD/L and hER or pSp1 and hER. Transient transfection and CAT assays were performed as described under Materials and Methods and results are expressed relative to DMSO (control, set at 100%). Results are expressed as means ± SE for three replicate determinations for each treatment group; the α-naphthoflavone and antisense Arnt studies were performed separately and both treatments significantly (P < 0.05) decreased E2-induced CAT activity. In contrast, antisense Arnt did not affect induction of CAT activity in cells transfected with pSp1, a construct containing a consensus Sp1 oligonucleotide insert (35) .
band intensity with [ 32 P]CD/L M1 (lane 4), confirming the requirement for the intact core DRE sequence for AhR/ARNT-mediated enhancement of retarded band formation as well as for transactivation by E2 (Fig. 1) . Formation of the Sp1/ER-[ 32 P]CD/L M1 retarded band was significantly decreased after co-incubation with excess unlabeled Sp1 (lane 5) or CD/L (lane 6) oligonucleotide.
Interaction of ER/Sp1 and AhR/ARNT complexes
Interactions of the AhR/ARNT proteins with ER/Sp1 were investigated by co-incubating [ 35 S]ER plus AhR/ARNT in the presence or absence of Sp1 protein followed by treatment with anti-Sp1, anti-AhR or anti-ARNT antibodies (Fig. 7) . Anti-Sp1, anti-AhR and anti-ARNT antibodies immunoprecipitate hormone-induced footprint was associated with a third E2-responsive motif in the cathepsin D gene proximal promoter region. Previous studies in this laboratory have demonstrated that ER activation of gene expression can be observed using constructs containing a consensus Sp1 oligonucleotide (35) and a comparable GC-rich region from the c-fos proto-oncogene promoter (43) . Both ER and Sp1 physically interact (35) and both the physical and functional interactions of ER and Sp1 proteins with GC-rich elements reported in previous studies (35, 43) were also observed for CD/L and pCD/L. For example, wild-type pCD/L was E2-responsive, whereas pCD/L M1 , pCD/L M2 and pCD/L M3 , containing mutations in the GC-rich, core DRE (-130 to -126) and both the GC-rich and core DRE sequences, were not hormone responsive. In MCF-7 cells transfected with pCD/L, E2 induction was observed only after co-transfection with wild-type hER or HE11, in which the DNA binding domain is deleted (Fig. 1) . ER enhanced the intensity of the Sp1-CD/L retarded band (Fig. 3) , but did not form a ternary complex in gel mobility shift assays. This type of enhanced protein-DNA binding has been observed in other studies showing that HTLV-1 Tax, SREPB and cyclin D1 enhance bZIP, Sp1 and ER binding to their respective enhancer sequences without forming a ternary complex (44) (45) (46) . The mechanism associated with ER/Sp1 gene activation through GC-rich elements is analogous to hormone-induced gene expression via ER-AP-1 complex interactions with cognate AP-1 promoter sequences (47, 48) .
Role of the core DRE sequence in CD/L:AhR/ARNT binding and interaction with ER/Sp1
Initial transient transfection studies showed that E2 induced CAT activity in MCF-7 cells transfected with wild-type pCD/L (Fig. 1) but not pCD/L M1 , which contains a mutation in the core DRE motif (-130 to -126) adjacent to the Sp1 binding site. The core DRE sequence alone is not sufficient for ER activation, since E2 did not induce reporter gene activity in MCF-7 cells transfected with pDRE 3 or pCD/L M2 , which is mutated in the GC-rich site. Although mutation of the core DRE site within CD/L (to give CD/L M1 ) did not affect binding of Sp1 to [ 32 P]CD/L M1 or enhancement of this binding by ER (Fig. 6B) , ER activation of pCD/L M1 was not observed. These results suggest that E2 responsiveness of pCD/L may require the core DRE motif (-130 to -126) in concert with the adjacent GC-rich site. Interactions of Sp1 protein with other nuclear transcription factors such as retinoblastoma protein, p107, E2F1, bound AhR/ARNT and GATA-1, some of which are bound to their cognate response elements, has previously been reported (42,49-57) and therefore interactions of the unbound nuclear AhR complex with the core DRE motif and with the adjacent ER/Sp1 complex was further investigated.
Interaction of nuclear AhR complex with the core DRE in CD/L.
Immunofluorescence microscopy experiments clearly demonstrated that in untreated MCF-7 cells, AhR staining with anti-AhR antibodies was predominantly nuclear (Fig. 5iA-C) and similar results were obtained in cell fractionation studies (data not shown). Direct binding of AhR/ARNT to [ 32 P]CD/L was not observed in gel mobility shift assays, however, unlabeled in vitro translated AhR/ARNT binds the [ 32 P]DRE to form a retarded band (Fig. 4A , lane 3) and this band is also observed using nuclear extracts from untreated MCF-7 cells (data not shown). In addition, unlabeled CD/L competitively decreased the intensity of the AhR/ ARNT-[ 32 P]DRE (full sequence) retarded band (Fig. 4A, lane 5) , whereas unlabeled [ 32 P]CD/L M1 was inactive as a competitor (lane 6). Moreover, in UV cross-linking studies using BrdUsubstituted [ 32 P]CD/L, the AhR/ARNT complex specifically bound to this oligonucleotide (Fig. 4B) . These results suggest that the AhR/ARNT complex binds to the core DRE within CD/L, however, this interaction cannot be detected directly by non-denaturing gel electrophoresis.
DNA-dependent interactions of AhR/ARNT with ER/Sp1
. Interactions between AhR/ARNT and ER/Sp1 were further investigated in gel mobility shift assays using [ 32 P]CD/L and [ 32 P]CD/L M1 as probes for determining protein-protein interactions (Fig. 6A and B) . Both oligonucleotides bound Sp1 and co-incubation with ER enhanced formation of the Sp1-DNA retarded band as previously described (35) . The intensity of the ER/Sp1-[ 32 P]CD/L retarded band (Fig. 6A, lane 3) was increased 1.7-fold after co-incubation with equimolar concentrations of AhR/ARNT proteins (Fig. 6A,  lane 4) and the retarded band intensity was decreased after (Fig. 6B, lanes 2 and 3) , however, co-treatment with AhR/ARNT did not affect retarded band intensity. Thus, an intact core DRE sequence is required for AhR/ARNT-mediated enhancement of ER/Sp1-DNA complex formation and for E2-induced transactivation of wild-type pCD/L (Fig. 1) . (Fig. 7) . In contrast, all three antibodies co-immunoprecipitate [ 35 Figure 8 .
Direct interactions of AhR
Modulation of E2 responsiveness through AhR/ARNT.
Previous studies have shown that αNF is an AhR antagonist which inhibits formation of the transformed nuclear AhR complex (41, 58) . Thus, in MCF-7 cells, where AhR exists in both the cytosolic and nuclear fractions, addition of αNF would shift the AhR cytosol ↔ AhR nucleus equilibrium, resulting in higher cytosolic levels of this protein, and in MCF-7 cells transiently transfected with pCD/L and co-treated with 0.5 or 2.0 µM αNF there was a 40-50% decrease in induction of CAT activity by E2 (Fig. 5B) . Moreover, antisense Arnt expression also decreased this hormone-induced response (Fig. 5C) .
In summary, this study shows that in the absence of exogenous AhR ligand, interaction of the AhR/ARNT complex with the core DRE sequence in CD/L regulates both ER/Sp1 interactions with the adjacent Sp1 binding site and hormone-induced transactivation of the CD/L promoter sequence. Moreover, this study shows that three different enhancer sequences within the proximal region of the cathepsin D gene promoter mediate E2-induced transactivation (Fig. 8) . Current studies are focused on the cell-specific functionality of these elements and Sp1 core DRE motifs which are present in many other gene promoters.
